AMRX logo

AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

4,030
Mkt Cap
$3.95B
Volume
494,597.00
52W High
$15.42
52W Low
$7.02
PE Ratio
33.22
AMRX Fundamentals
Price
$12.35
Prev Close
$12.39
Open
$12.48
50D MA
$12.71
Beta
1.06
Avg. Volume
1.6M
EPS (Annual)
$0.2218
P/B
-87.03
Rev/Employee
$355,148.23
$6,547.48
Loading...
Loading...
News
all
press releases
Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
Although the revenue and EPS for Amneal (AMRX) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·6d ago
News Placeholder
More News
News Placeholder
Do Options Traders Know Something About Amneal Stock We Don't?
Investors need to pay close attention to AMRX stock based on the movements in the options market lately.
Zacks·9d ago
News Placeholder
Artemis Investment Management LLP Buys Shares of 124,899 Amneal Pharmaceuticals, Inc. $AMRX
Artemis Investment Management LLP bought a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 124,899 shares of the company's stock, valued at approximately $1...
MarketBeat·11d ago
News Placeholder
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Update
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) was the target of a large increase in short interest in the month of April. As of April 15th, there was short interest totaling 8,556,479...
MarketBeat·14d ago
News Placeholder
Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes"
Amneal (AMRX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks·15d ago
News Placeholder
Wall Street Analysts See a 34.77% Upside in Amneal (AMRX): Can the Stock Really Move This High?
The consensus price target hints at a 34.8% upside potential for Amneal (AMRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·15d ago
News Placeholder
Amneal Pharmaceuticals (AMRX) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·15d ago
News Placeholder
Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·15d ago
News Placeholder
Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?
Here is how Alignment Healthcare (ALHC) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.
Zacks·15d ago
News Placeholder
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Consensus Rating of "Moderate Buy" from Analysts
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eight analysts that are currently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and six have...
MarketBeat·15d ago
<
1
2
...
>

Latest AMRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.